+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Candidiasis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Candidiasis Therapeutics - Global Strategic Business Report

  • Report
  • November 2026
  • 474 Pages
  • Global
From
Celiac Diseases Drugs - Global Strategic Business Report - Product Thumbnail Image

Celiac Diseases Drugs - Global Strategic Business Report

  • Report
  • November 2026
  • 367 Pages
  • Global
From
From
Citicoline - Global Strategic Business Report - Product Thumbnail Image

Citicoline - Global Strategic Business Report

  • Report
  • November 2026
  • 461 Pages
  • Global
From
From
Insulin-like Growth Factors - Global Strategic Business Report - Product Thumbnail Image

Insulin-like Growth Factors - Global Strategic Business Report

  • Report
  • November 2026
  • 270 Pages
  • Global
From
Intravenous Ibuprofen - Global Strategic Business Report - Product Thumbnail Image

Intravenous Ibuprofen - Global Strategic Business Report

  • Report
  • November 2026
  • 470 Pages
  • Global
From
Levodopa - Global Strategic Business Report - Product Thumbnail Image

Levodopa - Global Strategic Business Report

  • Report
  • November 2026
  • 377 Pages
  • Global
From
Levothyroxine - Global Strategic Business Report - Product Thumbnail Image

Levothyroxine - Global Strategic Business Report

  • Report
  • November 2026
  • 268 Pages
  • Global
From
Antibacterial Products - Global Strategic Business Report - Product Thumbnail Image

Antibacterial Products - Global Strategic Business Report

  • Report
  • November 2026
  • 285 Pages
  • Global
From
Asperger Syndrome - Global Strategic Business Report - Product Thumbnail Image

Asperger Syndrome - Global Strategic Business Report

  • Report
  • November 2026
  • 275 Pages
  • Global
From
Barbiturate Drugs - Global Strategic Business Report - Product Thumbnail Image

Barbiturate Drugs - Global Strategic Business Report

  • Report
  • November 2026
  • 386 Pages
  • Global
From
GLP-1 Analogues - Global Strategic Business Report - Product Thumbnail Image

GLP-1 Analogues - Global Strategic Business Report

  • Report
  • November 2026
  • 474 Pages
  • Global
From
Delirium - Global Strategic Business Report - Product Thumbnail Image

Delirium - Global Strategic Business Report

  • Report
  • November 2026
  • 281 Pages
  • Global
From
Diabetic Ketoacidosis - Global Strategic Business Report - Product Thumbnail Image

Diabetic Ketoacidosis - Global Strategic Business Report

  • Report
  • November 2026
  • 279 Pages
  • Global
From
Phenobarbital - Global Strategic Business Report - Product Thumbnail Image

Phenobarbital - Global Strategic Business Report

  • Report
  • November 2026
  • 362 Pages
  • Global
From
Addison's Disease Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Addison's Disease Therapeutics - Global Strategic Business Report

  • Report
  • November 2026
  • 278 Pages
  • Global
From
Alopecia Treatment - Global Strategic Business Report - Product Thumbnail Image

Alopecia Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 287 Pages
  • Global
From
Anal Fissure Treatment - Global Strategic Business Report - Product Thumbnail Image

Anal Fissure Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 381 Pages
  • Global
From
Antifungal Treatment - Global Strategic Business Report - Product Thumbnail Image

Antifungal Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 590 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more